Images of brain tumors may only show up in a small subset of scans, so important details may be missed. Further, because labeling is typically a labor-intensive and time-consuming task, there are typically only a small number of medical imaging datasets available for analysis. The focus of this research is on the MRI images of the human brain, and an attempt has been made to propose a method for the accurate segmentation of these images to identify the correct location of tumors. In this study, GAN is utilized as a classification network to detect and segment of 3D MRI images. The 3D GAN network model provides dense connectivity, followed by rapid network convergence and improved information extraction. Mutual training in a generative adversarial network can bring the segmentation results closer to the labeled data to improve image segmentation. The BraTS 2021 dataset of 3D images was used to compare two experimental models.

Incomplete or faulty MRI sequences are common in clinical practice and can impair AI-based analyses that rely on complete multi-contrast data. The relative effectiveness of classical generative adversarial networks (GANs) versus modern diffusion and transformer-based models for clinically usable MRI synthesis remains unclear. This study evaluates cross-modality MRI synthesis using the BraTS 2019 brain tumour dataset, focusing on T1-to-T2 translation. We assess paired and unpaired CycleGAN models and compare them with two stronger but computationally intensive baselines, a conditional denoising diffusion probabilistic model (DDPM) and a transformer-enhanced GAN, using identical data splits and preprocessing pipelines. Inter-modality correlation was evaluated to estimate the achievable similarity between modalities. Conceptually, modality synthesis may be viewed as a representation-learning approach that compensates for missing imaging information by reconstructing clinically relevant features from available contrasts. Paired CycleGAN achieved correlations of $r\approx 0.92–0.93$ and SSIM $\approx 0.90–0.92$, approaching natural T1–T2 correlation ($r\approx 0.95$) while maintaining very fast inference (<50 ms/slice). Unpaired CycleGAN achieved $r\approx 0.74–0.78$ and SSIM $\approx 0.82–0.85$, producing clinically interpretable reconstructions without voxel-level supervision. DDPM achieved the highest fidelity (SSIM $\approx 0.93–0.95$, $r\approx 0.94$) but required substantially greater computational resources, while transformer-enhanced GAN performance was intermediate. Qualitative analysis showed that CycleGAN and DDPM best preserved tumour and tissue boundaries, whereas unpaired CycleGAN occasionally over-smoothed subtle lesions. These findings highlight the trade-off between fidelity and efficiency in cross-modality MRI synthesis, suggesting paired CycleGAN for time-sensitive clinical workflows and diffusion models as a computationally expensive accuracy upper bound.

Background/Objectives: Accurate classification of primary bone tumors from radiographic images is essential for early diagnosis, appropriate treatment planning, and informed clinical decision-making. While deep convolutional neural networks (CNNs) have shown strong performance in medical image analysis, their high computational complexity often limits real-world clinical deployment. This study aims to develop a lightweight yet highly accurate model for multi-class bone tumor classification. Methods: We propose Bone-CNN, a computationally efficient CNN architecture specifically designed for radiograph-based classification of primary bone tumors. The model was evaluated using the publicly available Figshare Radiograph Dataset of Primary Bone Tumors, which includes nine distinct tumor classes ranging from benign to malignant lesions and originates from multiple imaging centres. Performance was assessed through extensive experiments and compared against established baseline models, including DenseNet121, EfficientNet-B0, and MobileNetV2. Results: Bone-CNN achieved a test accuracy of 96.52% and a macro-AUC of 0.9989, outperforming all baseline architectures. Both quantitative and qualitative evaluations, including confusion matrices and ROC curve analyses, demonstrated robust and reliable discrimination between challenging tumor subtypes. Conclusions: The results indicate that Bone-CNN offers an excellent balance between accuracy and computational efficiency. Its strong performance and lightweight design highlight its suitability for clinical deployment, supporting effective and scalable radiograph-based assessment of primary bone tumors.

Accurate, automated delineation of adult diffuse gliomas from multi-parametric magnetic resonance imaging (mpMRI) is central to quantitative neuro-oncology. Volumetric 3D networks dominate the BraTS leaderboard but require expensive GPUs, long training cycles, and provide diminishing returns relative to their compute budget. Slice-wise 2D models, by contrast, discard inter-slice context that is informative for thin tumor rims and small enhancing foci. We introduce GDNet, a 2.5D multimodal MRI segmentation framework for adult glioma evaluated on the BraTS 2024 cohort. GDNet consumes a stack of three adjacent axial slices from the four standard BraTS modalities (T1, T1ce, T2, FLAIR) as a 12-channel input to a compact U-shaped encoder–decoder with Group Normalization and predicts whole tumor (WT), tumor core (TC), and enhancing tumor (ET) masks for the central slice. The training pipeline pairs the 2.5D backbone with: (i) Exponential Moving Average (EMA) of model weights with decay 0.999, (ii) mixed tumor-aware slice sampling (p_tumor = 0.50), (iii) a compound Cross-Entropy + Soft-Dice loss, and (iv) AdamW with warm-up plus cosine annealing under Automatic Mixed Precision. We performed a systematic, step-by-step ablation covering a 2D baseline, EMA + mixed sampling, tumor-centered crop fine-tuning, a GDNet-inspired architectural integration, a region-aware loss, 3-slice and 5-slice 2.5D inputs, and connected-component post-processing, and we report multi-seed results to quantify reproducibility. On the held-out BraTS 2024 test partition, the final 3-slice 2.5D GDNet achieved positive-only Dice scores of 0.791 ± 0.000 (WT), 0.736 ± 0.003 (TC), 0.654 ± 0.004 (ET), and a mean foreground positive-only Dice of 0.820 ± 0.000 across seeds; the all-slice mean foreground Dice exceeded 0.927 ± 0.000. Validation positive-only scores were 0.805 ± 0.002 (WT), 0.757 ± 0.004 (TC), 0.683 ± 0.009 (ET). The inter-seed standard deviation was small for every region (≤0.01 Dice points), indicating low inter-seed variance across the two seeds evaluated; with only two seeds, we regard this as preliminary evidence of training stability rather than a strong reproducibility claim. The ablation isolated EMA + mixed tumor sampling and the 2.5D context window as the dominant sources of improvement; notably, a GDNet-style architectural integration with a region-aware loss did not outperform the simpler 2.5D U-Net on positive-only WT/TC/ET, and light post-processing improved only all-slice Dice. A failure-mode audit found that the residual catastrophic predictions are concentrated on a small minority of diffuse, infiltrative tumors with mass effect. Conclusions: Carefully engineered training strategies, tumor-aware sampling, EMA stabilization, and a modest 2.5D context window recover a substantial fraction of the accuracy of much heavier 3D networks at a fraction of the compute, are reproducible across seeds, and outperform a heavier GDNet-inspired architectural variant on the same data. GDNet is therefore a practical and, pending external validation, potentially clinically deployable framework for multimodal glioma segmentation on workstation-class GPU hardware.